The revenue in the 'Anti-Diabetes Drugs' segment of the pharmaceuticals market in Italy was forecast to continuously increase between 2024 and 2029 by in total 0.3 billion euro (+33.71 percent). After the tenth consecutive increasing year, the indicator is estimated to reach 1.22 billion euro and therefore a new peak in 2029. Notably, the revenue of the 'Anti-Diabetes Drugs' segment of the pharmaceuticals market was continuously increasing over the past years.
Data provided by Statista Market Insights are estimates.
Definition: The Anti-Diabetes Drugs market covers drugs to treat the metabolism disorder diabetes mellitus. It includes insulin and non-insulinotropic drugs such as glucagen-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors. While patients with type 1 diabetes require lifelong insulin therapy, type 2 diabetes can also be treated with medication.
Additional information: Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).
Company examples: Novo Nordisk, Eli Lilly, Sanofi, Merck & Co
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Statista. (June 26, 2024). Revenue of the anti-diabetes drugs industry in Italy between 2019 and 2029 (in billion euros) [Graph]. In Statista. Retrieved November 05, 2024, from https://www.statista.com/forecasts/1342832/anti-diabetes-drugs-market-revenue-italy
Statista. "Revenue of the anti-diabetes drugs industry in Italy between 2019 and 2029 (in billion euros)." Chart. June 26, 2024. Statista. Accessed November 05, 2024. https://www.statista.com/forecasts/1342832/anti-diabetes-drugs-market-revenue-italy
Statista. (2024). Revenue of the anti-diabetes drugs industry in Italy between 2019 and 2029 (in billion euros). Statista. Statista Inc.. Accessed: November 05, 2024. https://www.statista.com/forecasts/1342832/anti-diabetes-drugs-market-revenue-italy
Statista. "Revenue of The Anti-diabetes Drugs Industry in Italy between 2019 and 2029 (in Billion Euros)." Statista, Statista Inc., 26 Jun 2024, https://www.statista.com/forecasts/1342832/anti-diabetes-drugs-market-revenue-italy
Statista, Revenue of the anti-diabetes drugs industry in Italy between 2019 and 2029 (in billion euros) Statista, https://www.statista.com/forecasts/1342832/anti-diabetes-drugs-market-revenue-italy (last visited November 05, 2024)
Revenue of the anti-diabetes drugs industry in Italy between 2019 and 2029 (in billion euros) [Graph], Statista, June 26, 2024. [Online]. Available: https://www.statista.com/forecasts/1342832/anti-diabetes-drugs-market-revenue-italy